Ribosomal proteins (rp) play a key role in the therapeutic effects of 5‐FU on tumours, and rpL3 is a key sensing molecule for 5‐FU and oxaliplatin‐induced ribosomal stress in colon and lung cancers. This evidence concerns the gene RPL3 and lung carcinoma.